{"id":"W2980209785","doi":"10.1182/blood.v124.21.1543.1543","title":"Time in Therapeutic Range (TTR) and Relative Efficacy and Safety of Treatment with Apixaban or Enoxaparin/Warfarin for Acute Symptomatic Venous Thromboembolism: An Analysis of the Amplify Trial Data","year":2014,"lang":"en","type":"article","venue":"Blood","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":5,"is_retracted":false,"has_abstract":true,"ca_institutions":"Thrombosis and Atherosclerosis Research Institute","funders":"","keywords":"Apixaban; Warfarin; Medicine; Quartile; Anesthesia; Rivaroxaban; Randomized controlled trial; Internal medicine; Surgery; Atrial fibrillation; Confidence interval","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.01653056,0.001077925,0.003059064,0.0005051519,0.0002704596,0.001367703,0.0009925549,0.001052207,0.002792737],"category_scores_gemma":[0.01817209,0.0003827848,0.004552346,0.0009361008,0.0008862401,0.001052425,0.0006657052,0.00185493,0.0002490235],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.000394388,"about_ca_system_score_gemma":0.0004956914,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.000327578,"about_ca_topic_score_gemma":0.0005331742,"domain_scores_codex":[0.9839274,0.01212027,0.00135616,0.001238845,0.001052803,0.0003044652],"domain_scores_gemma":[0.9758593,0.01598028,0.004757321,0.001885453,0.0006027597,0.0009148043],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"observational","study_design_scores_codex":[0.878258,0.0008931129,0.06508298,0.001891146,0.03537491,0.0001040113,0.0001388062,0.00159871,0.001464241,0.0003698492,0.001205801,0.01361823],"study_design_scores_gemma":[0.4714327,0.0994049,0.3020282,0.0005970756,0.10528,0.0008040448,0.0003376831,0.009033936,0.003347871,0.001968698,0.005533434,0.0002313102],"study_design_candidate":"observational","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9850757,0.01042451,0.0007699599,0.0003482589,0.00009635271,0.0002662678,0.001941812,0.00002365164,0.001053348],"genre_scores_gemma":[0.9946598,0.001423066,0.0007596939,0.0002289746,0.0002344077,0.000378602,0.001943794,0.00001461551,0.0003570781],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.01653056,"threshold_uncertainty_score":0.08742297,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.2371362607443016,"score_gpt":0.4074972759894043,"score_spread":0.1703610152451027,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}